Figure 4

mRNA expression levels of both RhoA and RhoC in ovarian carcinomas of International Federation of Gynecological and Obstetrics (FIGO) Stage III+IV tumors are significantly higher than those in Stage I + II tumors; * p = 0.0200, ** p = 0.0057.